These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28362259)

  • 1. Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate.
    Juul M; Bertl J; Guo Q; Nielsen MM; Świtnicki M; Hornshøj H; Madsen T; Hobolth A; Pedersen JS
    Elife; 2017 Mar; 6():. PubMed ID: 28362259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.
    Hornshøj H; Nielsen MM; Sinnott-Armstrong NA; Świtnicki MP; Juul M; Madsen T; Sallari R; Kellis M; Ørntoft T; Hobolth A; Pedersen JS
    NPJ Genom Med; 2018; 3():1. PubMed ID: 29354286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of coding and non-coding mutational hotspots in cancer genomes.
    Piraino SW; Furney SJ
    BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
    Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
    Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
    Nono AD; Chen K; Liu X
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined burden and functional impact tests for cancer driver discovery using DriverPower.
    Shuai S; ; Gallinger S; Stein LD;
    Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
    Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
    Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ncdDetect2: improved models of the site-specific mutation rate in cancer and driver detection with robust significance evaluation.
    Juul M; Madsen T; Guo Q; Bertl J; Hobolth A; Kellis M; Pedersen JS
    Bioinformatics; 2019 Jan; 35(2):189-199. PubMed ID: 29945188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models.
    Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S
    PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events.
    Ashouri A; Sayin VI; Van den Eynden J; Singh SX; Papagiannakopoulos T; Larsson E
    Nat Commun; 2016 Oct; 7():13197. PubMed ID: 28959951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
    Rheinbay E; Nielsen MM; Abascal F; Wala JA; Shapira O; Tiao G; Hornshøj H; Hess JM; Juul RI; Lin Z; Feuerbach L; Sabarinathan R; Madsen T; Kim J; Mularoni L; Shuai S; Lanzós A; Herrmann C; Maruvka YE; Shen C; Amin SB; Bandopadhayay P; Bertl J; Boroevich KA; Busanovich J; Carlevaro-Fita J; Chakravarty D; Chan CWY; Craft D; Dhingra P; Diamanti K; Fonseca NA; Gonzalez-Perez A; Guo Q; Hamilton MP; Haradhvala NJ; Hong C; Isaev K; Johnson TA; Juul M; Kahles A; Kahraman A; Kim Y; Komorowski J; Kumar K; Kumar S; Lee D; Lehmann KV; Li Y; Liu EM; Lochovsky L; Park K; Pich O; Roberts ND; Saksena G; Schumacher SE; Sidiropoulos N; Sieverling L; Sinnott-Armstrong N; Stewart C; Tamborero D; Tubio JMC; Umer HM; Uusküla-Reimand L; Wadelius C; Wadi L; Yao X; Zhang CZ; Zhang J; Haber JE; Hobolth A; Imielinski M; Kellis M; Lawrence MS; von Mering C; Nakagawa H; Raphael BJ; Rubin MA; Sander C; Stein LD; Stuart JM; Tsunoda T; Wheeler DA; Johnson R; Reimand J; Gerstein M; Khurana E; Campbell PJ; López-Bigas N; ; ; Weischenfeldt J; Beroukhim R; Martincorena I; Pedersen JS; Getz G;
    Nature; 2020 Feb; 578(7793):102-111. PubMed ID: 32025015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The landscape and driver potential of site-specific hotspots across cancer genomes.
    Juul RI; Nielsen MM; Juul M; Feuerbach L; Pedersen JS
    NPJ Genom Med; 2021 May; 6(1):33. PubMed ID: 33986299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
    Mularoni L; Sabarinathan R; Deu-Pons J; Gonzalez-Perez A; López-Bigas N
    Genome Biol; 2016 Jun; 17(1):128. PubMed ID: 27311963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SigsPack, a package for cancer mutational signatures.
    Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
    BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer.
    Rao Y; Ahmed N; Pritchard J; O'Brien EP
    BMC Bioinformatics; 2023 Dec; 24(1):462. PubMed ID: 38062391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining the coding and non-coding genome for cancer drivers.
    Li J; Drubay D; Michiels S; Gautheret D
    Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.